Cargando…

Type I Interferonopathies in Childhood

Type 1 interferonopathy is a novel context reflecting a group of inborn disorders sharing common pathway disturbances. This group of diseases is characterized by autoimmunity and autoinflammation caused by an upregulation of type 1 interferons (IFN)s due to certain genetic mutations. Several feature...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haşlak, Fatih, Kılıç Könte, Elif, Aslan, Esma, Şahin, Sezgin, Kasapçopur, Özgür
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2023
Materias:	Invited Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175883/ https://www.ncbi.nlm.nih.gov/pubmed/37161741 http://dx.doi.org/10.4274/balkanmedj.galenos.2023.2023-4-78

Ejemplares similares

Juvenile spondyloartropathies
por: Yıldız, Mehmet, et al.
Publicado: (2022)

Autoinflammatory Diseases in Childhood
por: Yıldız, Mehmet, et al.
Publicado: (2020)

Childhood Rheumatic Diseases and COVID-19 Pandemic: An Intriguing Linkage and a New Horizon
por: Haşlak, Fatih, et al.
Publicado: (2020)

Non-Rheumatic Chronic Comorbidities in Children with Juvenile Idiopathic Arthritis
por: Haşlak, Fatih, et al.
Publicado: (2023)

A recently explored aspect of the iceberg named COVID-19: multisystem inflammatory syndrome in children (MIS-C)
por: Haslak, Fatih, et al.
Publicado: (2021)

Juvenile Idiopathic Arthritis
por: Barut, Kenan, et al.
Publicado: (2017)

Management of childhood-onset autoinflammatory diseases during the COVID-19 pandemic
por: Haslak, Fatih, et al.
Publicado: (2020)

Psychosocial and clinical effects of the COVID-19 pandemic in patients with childhood rheumatic diseases and their parents
por: Durcan, Gizem, et al.
Publicado: (2021)

Type I interferonopathies in pediatric rheumatology
por: Volpi, Stefano, et al.
Publicado: (2016)

The type I interferonopathies: 10 years on
por: Crow, Yanick J., et al.
Publicado: (2021)

Pediatric Behçet's Disease
por: Yildiz, Mehmet, et al.
Publicado: (2021)

Type I Interferonopathies in Children: An Overview
por: d'Angelo, Debora M., et al.
Publicado: (2021)

Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenitis Syndrome: A Single-Center Experience
por: Yıldız, Mehmet, et al.
Publicado: (2022)

The impact of COVID-19 on clinical course and treatment among patients with juvenile systemic sclerosis
por: Adrovic, Amra, et al.
Publicado: (2022)

Asymptomatic SARS-CoV-2 seropositivity: patients with childhood-onset rheumatic diseases versus healthy children
por: Haslak, Fatih, et al.
Publicado: (2022)

Type I interferon–mediated monogenic autoinflammation: The type I interferonopathies, a conceptual overview
por: Rodero, Mathieu P., et al.
Publicado: (2016)

Myasthenia Gravis: An Acquired Interferonopathy?
por: Payet, Cloé A., et al.
Publicado: (2022)

Covid-19–Associated Myopathy Caused by Type I Interferonopathy
por: Manzano, Giovanna S., et al.
Publicado: (2020)

Clinical spectrum and currently available treatment of type I interferonopathy Aicardi–Goutières syndrome
por: Dell’Isola, Giovanni Battista, et al.
Publicado: (2023)

Lung involvement in monogenic interferonopathies
por: Cazzato, Salvatore, et al.
Publicado: (2020)

Human RELA dominant-negative mutations underlie type I interferonopathy with autoinflammation and autoimmunity
por: Moriya, Kunihiko, et al.
Publicado: (2023)

Type I Interferonopathy due to a Homozygous Loss-of-Inhibitory Function Mutation in STAT2
por: Zhu, Gaofeng, et al.
Publicado: (2023)

Efficacy of Baricitinib in the Treatment of Chilblains Associated With Aicardi‐Goutières Syndrome, a Type I Interferonopathy
por: Meesilpavikkai, Kornvalee, et al.
Publicado: (2019)

Fine-tuning of type I IFN-signaling in microglia — implications for homeostasis, CNS autoimmunity and interferonopathies
por: Goldmann, Tobias, et al.
Publicado: (2016)

Human Disease Phenotypes Associated with Loss and Gain of Function Mutations in STAT2: Viral Susceptibility and Type I Interferonopathy
por: Duncan, Christopher James Arthur, et al.
Publicado: (2021)

Monogenic interferonopathy presenting as CMV infection in infancy
por: Schütz, C, et al.
Publicado: (2015)

Efficacy and safety of baricitinib in Japanese patients with autoinflammatory type I interferonopathies (NNS/CANDLE, SAVI, And AGS)
por: Kanazawa, Nobuo, et al.
Publicado: (2023)

Identification of type I interferonopathies using blood interferon signature: the experience of a pediatric rheumatology center
por: Volpi, S, et al.
Publicado: (2015)

Type 1 Diabetes and Type 1 Interferonopathies: Localization of a Type 1 Common Thread of Virus Infection in the Pancreas
por: Jean-Baptiste, Virginie S.E., et al.
Publicado: (2017)

Biologics in juvenile idiopathic arthritis-main advantages and major challenges: A narrative review
por: ADROVIC, Amra, et al.
Publicado: (2020)

Increased Frequency of Febrile Seizures in Two Periodic Fever Syndromes: Familial Mediterranean Fever and PFAPA Syndrome
por: Kılıç, Hüseyin, et al.
Publicado: (2022)

Homozygous STAT2 gain-of-function mutation by loss of USP18 activity in a patient with type I interferonopathy
por: Gruber, Conor, et al.
Publicado: (2020)

Type I interferonopathies with novel compound heterozygous TREX1 mutations in two siblings with different symptoms responded to tofacitinib
por: Zhang, Shiyu, et al.
Publicado: (2021)

Janus Kinase Inhibitors in the Treatment of Type I Interferonopathies: A Case Series From a Single Center in China
por: Li, Wendao, et al.
Publicado: (2022)

Neuroinflammation in Parkinson’s Disease and its Treatment Opportunities
por: Çınar, Elif, et al.
Publicado: (2022)

Idiopathic Pulmonary Hemosiderosis in a Child with Recurrent Macrophage Activation Syndrome Secondary to Systemic Juvenile Idiopathic Arthritis
por: Barut, Kenan, et al.
Publicado: (2017)

Fatigue and sleep in children and adolescents with juvenile idiopathic arthritis:a cross-sectional study
por: TARAKCI, Ela, et al.
Publicado: (2019)

JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies
por: Sanchez, Gina A. Montealegre, et al.
Publicado: (2018)

Comparisons of Clinical Features and Outcomes of COVID-19 between Patients with Pediatric Onset Inflammatory Rheumatic Diseases and Healthy Children
por: Haslak, Fatih, et al.
Publicado: (2022)

Multidimensional definition of the interferonopathy of Down syndrome and its response to JAK inhibition
por: Galbraith, Matthew D., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ir4iu7tfdot4phl1h35ois5640